121 related articles for article (PubMed ID: 23414143)
1. Psoralen derivatives as inhibitors of NF-κB/DNA interaction: synthesis, molecular modeling, 3D-QSAR, and biological evaluation.
Marzaro G; Guiotto A; Borgatti M; Finotti A; Gambari R; Breveglieri G; Chilin A
J Med Chem; 2013 Mar; 56(5):1830-42. PubMed ID: 23414143
[TBL] [Abstract][Full Text] [Related]
2. Virtual screening against nuclear factor κB (NF-κB) of a focus library: Identification of bioactive furocoumarin derivatives inhibiting NF-κB dependent biological functions involved in cystic fibrosis.
Piccagli L; Borgatti M; Nicolis E; Bianchi N; Mancini I; Lampronti I; Vevaldi D; Dall'Acqua F; Cabrini G; Gambari R
Bioorg Med Chem; 2010 Dec; 18(23):8341-9. PubMed ID: 20980154
[TBL] [Abstract][Full Text] [Related]
3. Development of a novel furocoumarin derivative inhibiting NF-κB dependent biological functions: design, synthesis and biological effects.
Borgatti M; Chilin A; Piccagli L; Lampronti I; Bianchi N; Mancini I; Marzaro G; dall'Acqua F; Guiotto A; Gambari R
Eur J Med Chem; 2011 Oct; 46(10):4870-7. PubMed ID: 21864947
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of novel trimethylangelicin analogues targeting nuclear factor kB (NF-kB).
Marzaro G; Lampronti I; D'Aversa E; Sacchetti G; Miolo G; Vaccarin C; Cabrini G; Dechecchi MC; Gambari R; Chilin A
Eur J Med Chem; 2018 May; 151():285-293. PubMed ID: 29627723
[TBL] [Abstract][Full Text] [Related]
5. Theoretical studies on pyrimidine substituent derivatives as dual inhibitors of AP-1 and NF-kappaB.
Qian L; Liao SY; Huang ZL; Shen Y; Zheng KC
J Mol Model; 2010 Jun; 16(6):1139-50. PubMed ID: 19943176
[TBL] [Abstract][Full Text] [Related]
6. Targeting the NF-κB/IκBα complex via fragment-based E-Pharmacophore virtual screening and binary QSAR models.
Kanan T; Kanan D; Erol I; Yazdi S; Stein M; Durdagi S
J Mol Graph Model; 2019 Jan; 86():264-277. PubMed ID: 30415122
[TBL] [Abstract][Full Text] [Related]
7. 3D-QSAR and docking studies on ursolic acid derivatives for anticancer activity based on bladder cell line T24 targeting NF-kB pathway inhibition.
Yadav D; Nath Mishra B; Khan F
J Biomol Struct Dyn; 2019 Sep; 37(14):3822-3837. PubMed ID: 30261824
[TBL] [Abstract][Full Text] [Related]
8. Differential Effects of Angelicin Analogues on NF-
Lampronti I; Manzione MG; Sacchetti G; Ferrari D; Spisani S; Bezzerri V; Finotti A; Borgatti M; Dechecchi MC; Miolo G; Marzaro G; Cabrini G; Gambari R; Chilin A
Mediators Inflamm; 2017; 2017():2389487. PubMed ID: 29089668
[TBL] [Abstract][Full Text] [Related]
9. 4-Sulfonyloxy/alkoxy benzoxazolone derivatives with high anti-inflammatory activities: Synthesis, biological evaluation, and mechanims of action via p38/ERK-NF-κB/iNOS pathway.
Tang L; Luo JR; Wang XY; Zhao B; Ge R; Liang TG; Ban SR; Li QS
Chem Biol Drug Des; 2021 Feb; 97(2):200-209. PubMed ID: 32915501
[TBL] [Abstract][Full Text] [Related]
10. Discovery of Novel DPP-IV Inhibitors as Potential Candidates for the Treatment of Type 2
Musoev A; Numonov S; You Z; Gao H
Molecules; 2019 Aug; 24(16):. PubMed ID: 31394858
[TBL] [Abstract][Full Text] [Related]
11. Psoralen derivatives as inhibitors of NF-κB interaction: the critical role of the furan ring.
Marzaro G; Lampronti I; Borgatti M; Manzini P; Gambari R; Chilin A
Mol Divers; 2015 Aug; 19(3):551-61. PubMed ID: 25869956
[TBL] [Abstract][Full Text] [Related]
12. A molecular modeling study of inhibitors of nuclear factor kappa-B (p50)--DNA binding.
Pande V; Sharma RK; Inoue J; Otsuka M; Ramos MJ
J Comput Aided Mol Des; 2003 Dec; 17(12):825-36. PubMed ID: 15124931
[TBL] [Abstract][Full Text] [Related]
13. Evans Blue is an inhibitor of nuclear factor-kappa B (NF-kappaB)-DNA binding.
Sharma RK; Otsuka M; Pande V; Inoue J; João Ramos M
Bioorg Med Chem Lett; 2004 Dec; 14(24):6123-7. PubMed ID: 15546742
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of imperatorin analogs and their evaluation as acetylcholinesterase and butyrylcholinesterase inhibitors.
Granica S; Kiss AK; Jarończyk M; Maurin JK; Mazurek AP; Czarnocki Z
Arch Pharm (Weinheim); 2013 Nov; 346(11):775-82. PubMed ID: 24123207
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity and Anti-inflammatory Activity of Flavonoid Derivatives Targeting NF-kappaB.
Naik KK; Thangavel S; Alam A
Recent Pat Inflamm Allergy Drug Discov; 2017; 10(2):119-132. PubMed ID: 27842477
[TBL] [Abstract][Full Text] [Related]
16. Molecular modeling studies on benzimidazole carboxamide derivatives as PARP-1 inhibitors using 3D-QSAR and docking.
Zeng H; Zhang H; Jang F; Zhao L; Zhang J
Chem Biol Drug Des; 2011 Sep; 78(3):333-52. PubMed ID: 21585709
[TBL] [Abstract][Full Text] [Related]
17. Insight into the interaction mechanism of human SGLT2 with its inhibitors: 3D-QSAR studies, homology modeling, and molecular docking and molecular dynamics simulations.
Dong L; Feng R; Bi J; Shen S; Lu H; Zhang J
J Mol Model; 2018 Mar; 24(4):86. PubMed ID: 29511885
[TBL] [Abstract][Full Text] [Related]
18. Combined 3D-QSAR modeling and molecular docking study on indolinone derivatives as inhibitors of 3-phosphoinositide-dependent protein kinase-1.
AbdulHameed MD; Hamza A; Liu J; Zhan CG
J Chem Inf Model; 2008 Sep; 48(9):1760-72. PubMed ID: 18717540
[TBL] [Abstract][Full Text] [Related]
19. Identification of the Structural Features of Guanine Derivatives as MGMT Inhibitors Using 3D-QSAR Modeling Combined with Molecular Docking.
Sun G; Fan T; Zhang N; Ren T; Zhao L; Zhong R
Molecules; 2016 Jun; 21(7):. PubMed ID: 27347909
[TBL] [Abstract][Full Text] [Related]
20. Identification of curcumin derivatives as human glyoxalase I inhibitors: A combination of biological evaluation, molecular docking, 3D-QSAR and molecular dynamics simulation studies.
Yuan M; Luo M; Song Y; Xu Q; Wang X; Cao Y; Bu X; Ren Y; Hu X
Bioorg Med Chem; 2011 Feb; 19(3):1189-96. PubMed ID: 21237663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
